Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.
Press releases published on May 8, 2025
Sumihiro Investments and EDGE Partners Join Forces to Advance Foreign Direct Investment and Economic Growth
EIN Presswire
·
May 8, 2025
Partnership Combines Decades of Global Investment Expertise Helping International Companies Successfully Enter and Grow in US Markets DENVER, CO, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- Sumihiro Investments, LLC and EDGE Partners, LLC announced …
Dome Fest West 2025 Closes Celebrating Excellence in Fulldome Filmmaking
EIN Presswire
·
May 8, 2025
Festival Concludes with Gala Awards Ceremony and Sold-Out Psychedelic Program in Boulder, CO BOULDER, CO, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- Dome Fest West 2025 Celebrates Outstanding Achievement in Fulldome Filmmaking Festival …
Giant Screen Cinema Association and Dome Fest West Announce Partnership to Advance Immersive Cinema
EIN Presswire
·
May 8, 2025
The GSCA and Dome Fest West join forces to strengthen the global immersive cinema community and foster innovation in large-format and dome-based media. BOULDER, CO, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- The Giant Screen Cinema Association ( …
PteroDynamics Showcases the Transwing VTOL UAS at XPONENTIAL 2025 and DSEI Japan 2025
EIN Presswire
·
May 8, 2025
COLORADO SPRINGS, CO, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- PteroDynamics Inc., an innovator in autonomous vertical takeoff and landing (VTOL) aircraft systems, today announced that it is exhibiting at XPONENTIAL 2025, the yearly gathering of …
Draganfly Announces First Quarter Results of 2025
GlobeNewswire
·
May 8, 2025
Vancouver, BC., May 08, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, is pleased to announce its first quarter …
Tarsus to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 8, 2025
IRVINE, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) today announced that management plans to participate in the following upcoming investor conferences: Bank of America Securities 2025 Health Care Conference on …
Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering
GlobeNewswire
·
May 8, 2025
Hopewell, New Jersey, May 08, 2025 (GLOBE NEWSWIRE) -- Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds” or the “Company”), a clinical stage biopharmaceutical company that is in the process of developing Apitox, an intradermally …
Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights
GlobeNewswire
·
May 8, 2025
- Sharpened product candidate focus on its next-generation ADC portfolio, following strategic review and pipeline reprioritization - - Promising preclinical results with STRO-004 and dual-payload ADC, as well as STRO-006 programs presented at AACR 2025 and …
BioSyent Schedules First Quarter Earnings Release for May 15, 2025
GlobeNewswire
·
May 8, 2025
MISSISSAUGA, Ontario, May 08, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months ended March 31, 2025 on Thursday, May 15, 2025 after market hours. A presentation …
Galecto Reports First Quarter 2025 Operating and Financial Results
GlobeNewswire
·
May 8, 2025
BOSTON, May 08, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, announced its operating and financial results for the quarter …
Theriva Biologics Announces Closing of $7.5 Million Public Offering
GlobeNewswire
·
May 8, 2025
ROCKVILLE, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, …
Serina Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights
GlobeNewswire
·
May 8, 2025
On track for first patient dosing of SER-252 in Phase 1b clinical trial in advanced Parkinson’s disease in Q4 2025 Strengthened balance sheet with recent financing Advancing innovative POZ Platform across multiple therapeutic modalities Two new seasoned …
Fennec Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025
GlobeNewswire
·
May 8, 2025
RESEARCH TRIANGLE PARK, N.C., May 08, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its first quarter 2025 financial results …
Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
Data cutoff date for Phase 2b NAVIGATE trial efficacy reached on April 30, 2025; top-line data readout expected in late June 2025 Nature Microbiology publication highlights preclinical data and the potential of CD388 as a potent, universal antiviral for …
PacBio Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
MENLO PARK, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2025. First quarter results: Q1 2025 Q1 2024 Revenue $37.2 million $38.8 million Instrument revenue $11.0 million …
Rackspace Technology Reports First Quarter 2025 Results
GlobeNewswire
·
May 8, 2025
Revenue of $665 million in the First Quarter, down 4% Year-over-Year Private Cloud Revenue was $250 million, down 7% Year-over-Year Public Cloud Revenue was $416 million, down 2% Year-over-Year First Quarter 2025 Cash Flow From Operating Activities was $13 …
Turtle Beach Corporation Announces Growth in Revenue, Adjusted EBITDA and Gross Margins in First Quarter 2025 Results and $75 Million Share Repurchase Program
GlobeNewswire
·
May 8, 2025
–Net Revenue of $63.9 million, up 14% compared to prior year– –Gross Margin improved to 36.6%, an increase of approximately 470 basis points compared to prior year– –Net Loss of $(0.7) million compared to Net Income of $0.2 million in prior year– –Adjusted …
Microchip Technology Announces Quarterly Cash Dividend on Common Stock of 45.5 Cents Per Share
GlobeNewswire
·
May 8, 2025
CHANDLER, Ariz., May 08, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that its Board of Directors declared a quarterly cash …
Microchip Technology Announces Financial Results For Fourth Quarter and Fiscal Year 2025
GlobeNewswire
·
May 8, 2025
For the quarter ended March 31, 2025 Net sales of $970.5 million, declined 5.4% sequentially and 26.8% from the year ago quarter. The midpoint of our guidance provided on February 6, 2025 was net sales of $960.0 million. On a GAAP basis: gross profit of …
INmune Bio Inc. Announces First Quarter 2025 Results and Provides Business Update
GlobeNewswire
·
May 8, 2025
BOCA RATON, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage biotechnology company targeting inflammation and immunology through the innate immune system, today announces its financial results for the …